Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Journey Medical Corporation Common Stock (DERM)

Pharmaceutical Preparations

https://www.journeymedicalcorp.com

Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.

9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE, AZ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/12/2021

Market Cap

89,629,756

Shares Outstanding

12,510,000

Weighted SO

18,508,449

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

EVOK --.--%

JUPW --.--%

AVDL --.--%

AQST --.--%

CRLBF --.--%

CURLF --.--%

TCNNF --.--%

ACB --.--%

Beta

0.9350

Last Div

0.0000

Range

1.78-8.11

Chg

-0.0814

Avg Vol

85751

Mkt Cap

89629756

Exch

NASDAQ

Country

US

Phone

480 434 6670

DCF Diff

2.7852

DCF

4.7852

Div Yield

0.0000

P/S

1.1538

EV Multiple

19.0581

P/FV

7.9278

Div Yield %

0.0000

P/E

106.2212

PEG

4.5460

Payout

0.0000

Current Ratio

1.3609

Quick Ratio

1.0772

Cash Ratio

0.7003

DSO

49.1719

DIO

137.0395

Op Cycle

186.2114

DPO

210.2771

CCC

-24.0657

Gross Margin

0.6679

Op Margin

0.0273

Pretax Margin

0.0137

Net Margin

0.0109

Eff Tax Rate

0.9527

ROA

0.0129

ROE

0.0544

ROCE

0.0684

NI/EBT

0.7923

EBT/EBIT

0.5009

EBIT/Rev

0.0273

Debt Ratio

0.3499

D/E

2.0192

LT Debt/Cap

0.6361

Total Debt/Cap

0.6688

Int Coverage

1.5139

CF/Debt

-0.3454

Equity Multi

5.7715

Rec Turnover

7.4229

Pay Turnover

1.7358

Inv Turnover

2.6635

FA Turnover

1412.3818

Asset Turnover

1.1916

OCF/Share

-0.3940

FCF/Share

-0.1439

Cash/Share

1.1960

OCF/Sales

-0.1014

FCF/OCF

0.3652

CF Coverage

-0.3454

ST Coverage

-2.5750

CapEx Coverage

-1.5754

Div&CapEx Cov

-1.5754

P/BV

7.9278

P/B

7.9278

P/S

1.1538

P/E

106.2212

P/FCF

-31.1539

P/OCF

-11.3678

P/CF

-11.3678

PEG

4.5460

P/S

1.1538

EV Multiple

19.0581

P/FV

7.9278

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Dec 26, 09:29 What Awaits These 4 Drug Stocks That More Than Doubled in 2023? GlobeNewswire Inc. Oct 31, 08:30 Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

Revenue Product Segmentation